U.S. scientists say live, weakened versions of differing strains of avian flu viruses have offered protection when tested in mice and ferrets.
Researchers say their findings are encouraging because they demonstrate the ability to create a vaccine based on one particular strain of the H5N1 flu virus that could potentially protect against different emerging H5N1 flu strains.
"If an influenza pandemic were imminent or under way, we would need a vaccine that could stimulate immunity quickly, preferably with a single dose," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The encouraging findings of this study suggest vaccines based on live, but weakened, versions of the H5N1 avian influenza virus may quickly stimulate protective immunity.
"We are further exploring this live, attenuated vaccine strategy as one of several tools that we hope to have available in the event of an influenza pandemic," he added.
Senior investigator Dr. Kanta Subbarao and co-chief investigator Dr. Brian Murphy explain the research in the Sept. 12 issue of PLoS Medicine.
Copyright 2006 by United Press International
Related stories:
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
New vaccine against deadliest strain of avian flu tested by scientists
A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh’s Center for Vaccine Research and Novavax Inc.
New field-deployable biosensor detects avian influenza virus in minutes instead of days
Quick identification of avian influenza infection in poultry is critical to controlling outbreaks, but current detection methods can require several days to produce results.
Avian influenza on people's minds
Researchers at the Food Policy Institute at the Rutgers New Jersey Agricultural Experiment Station have conducted a nationwide survey of public knowledge, attitudes, intentions and behaviors related to the threat of highly pathogenic avian influenza. The researchers conducted a total of 1200 telephone interviews on the topic between May 3 and June 5, 2006.
Researchers sequence western H5N1 virus genomes
In a paper in the May issue of
Emerging Infectious Diseases, an international team of researchers report the first ever large-scale sequencing of western genomes of the deadly avian influenza virus, H5N1.
'Protecting virus' offers instant flu protection and converts flu infections into their own vaccines
Research led by Professor Nigel Dimmock at the University of Warwick is developing an entirely new method of protecting against flu. This has been shown to protect animals against various strains of flu, and could offer protection against the full range of influenza A infections, including H5N1 and any new pandemic or epidemic strains infecting humans.
USDA criticized for its bird flu planning
An audit by the U.S. Agriculture Department's inspector general finds the department has failed to develop a plan to detect bird flu in poultry and birds.
Penn animal study identifies new DNA weapon against avian flu
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus. This approach could allow for the build up of vaccine reserves that could be easily and effectively dispensed in case of an epidemic. This study was published last week in
PLoS ONE.